These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
455 related items for PubMed ID: 9934358
1. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum. Rea TH, Sieling PA. Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358 [Abstract] [Full Text] [Related]
2. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [Abstract] [Full Text] [Related]
3. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study]. de Carsalade GY, Achirafi A, Flageul B. Acta Leprol; 2003 Mar; 12(3):117-22. PubMed ID: 15040702 [Abstract] [Full Text] [Related]
4. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Becx-Bleumink M, Berhe D. Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359 [Abstract] [Full Text] [Related]
5. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide. Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM. Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975 [Abstract] [Full Text] [Related]
6. Risk factors for erythema nodosum leprosum. Manandhar R, LeMaster JW, Roche PW. Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406 [Abstract] [Full Text] [Related]
7. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients. Sampaio EP, Malta AM, Sarno EN, Kaplan G. Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260 [Abstract] [Full Text] [Related]
8. Leprosy reactions in postelimination stage: the Bangladesh experience. Mowla MR, Ara S, Mizanur Rahman AFM, Tripura SP, Paul S. J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670 [Abstract] [Full Text] [Related]
9. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy. Kumar A, Girdhar A, Girdhar BK. Acta Leprol; 2003 Apr; 12(3):123-8. PubMed ID: 15040703 [Abstract] [Full Text] [Related]
10. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions. Memon RA, Kifayet A, Shahid F, Lateef A, Chiang J, Hussain R. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748 [Abstract] [Full Text] [Related]
11. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions. Chakrabarty AK, Kashyap A, Sehgal VN, Saha K. Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112 [Abstract] [Full Text] [Related]
17. The role of thalidomide in the management of erythema nodosum leprosum. Walker SL, Waters MF, Lockwood DN. Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771 [Abstract] [Full Text] [Related]